COLL vs PAHC: fair value comparison
Collegium Pharmaceutical, Inc. and Phibro Animal Health Corporation · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, COLL currently sits closer to the top of our discount ranking. COLL carries the stronger quality grade.
| COLL | PAHC | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $35.58 | $37.15 |
| 12-month range | $31.78–$47.11 | $29.76–$54.68 |
| Sector rank | #42 of 113 Healthcare | #46 of 113 Healthcare |
| Quality grade | C- | D |
| Momentum grade | — | D |
| Leverage | High | High |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The bottom quarter | The lower-middle quarter |
Full single-stock breakdowns: COLL fair value analysis · PAHC fair value analysis